Published in J Neurol on April 30, 2007
PET/CT in diagnosis of movement disorders. Ann N Y Acad Sci (2011) 1.05
Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology (2010) 0.91
Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One (2012) 0.88
Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS One (2012) 0.85
An altered GABA-A receptor function in spinocerebellar ataxia type 6 and familial hemiplegic migraine type 1 associated with the CACNA1A gene mutation. BBA Clin (2014) 0.76
Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography. PLoS One (2017) 0.75
CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. Neuroimage Clin (2016) 0.75
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain (2003) 2.25
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry (1986) 1.84
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol (1997) 1.56
Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol (1999) 1.48
A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology (1994) 1.21
Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol (1999) 1.11
Estimating smoothness in statistical parametric maps: variability of p values. J Comput Assist Tomogr (1995) 1.10
Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum Brain Mapp (2000) 1.09
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med (2003) 1.08
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol (2000) 1.05
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol (2005) 1.02
Cognitive deficits in spinocerebellar ataxia 2. Brain (1999) 0.98
Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol (2001) 0.98
Autosomal dominant cerebellar ataxia (SCA6): clinical, genetic and neuropathological study in a family. Acta Neuropathol (1998) 0.95
Extrapyramidal motor signs in degenerative ataxias. Arch Neurol (2000) 0.94
The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol (2003) 0.93
Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain (1997) 0.93
Executive and emotional dysfunction in Machado-Joseph disease. Mov Disord (2002) 0.92
Atrophy pattern in SCA2 determined by voxel-based morphometry. Neuroreport (2003) 0.90
Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6. J Magn Reson Imaging (2001) 0.87
Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy. Ann Nucl Med (1989) 0.85
Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism. Ann Neurol (2004) 0.85
Supratentorial atrophy in spinocerebellar ataxia type 2: MRI study of 20 patients. J Neurol (1999) 0.84
Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol (1988) 0.83
Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol (1994) 0.83
Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol (1998) 0.82
Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol (1997) 0.82
Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci (1997) 0.82
Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds. Arch Neurol (2003) 0.82
Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease. J Neurol Neurosurg Psychiatry (1998) 0.81
Prolonged cortical relay time of long latency reflex and central motor conduction in patients with spinocerebellar ataxia type 6. Clin Neurophysiol (2003) 0.81
Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect. Brain (2002) 0.80
Metabolic characterization of spinocerebellar ataxia type 6. Arch Neurol (2001) 0.78
Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol (2001) 0.77
Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease. Neurology (1997) 0.75
Prolonged central motor conduction time of lower limb muscle in spinocerebellar ataxia 6. J Clin Neurosci (2004) 0.75
[Analysis of regional cerebral blood flow and distribution volume in Machado-Joseph disease by iodine-123I IMP single photon emission computed tomography]. Rinsho Shinkeigaku (2001) 0.75
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res (2005) 1.86
Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol (2012) 1.76
A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain (2003) 1.58
Early detection of periodic sharp wave complexes on EEG by independent component analysis in patients with Creutzfeldt-Jakob disease. J Clin Neurophysiol (2008) 1.42
Allele-specific all-or-none PCR product diagnostic strategy for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies. J Chin Med Assoc (2006) 1.39
F-18 FDG PET/CT in evaluation of pulmonary sclerosing hemangioma. Clin Nucl Med (2011) 1.24
Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release (2012) 1.14
Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest (2008) 1.08
FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. Neurobiol Aging (2010) 1.08
A statistical method for evaluation quality of medical images: a case study in bit discarding and image compression. Comput Med Imaging Graph (2004) 1.07
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients. Biochem Biophys Res Commun (2007) 1.06
Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol (2009) 1.06
The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One (2011) 1.05
MR features of abdominal splenosis. AJR Am J Roentgenol (2003) 1.02
NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. PLoS One (2011) 1.00
SCA17 repeat expansion: mildly expanded CAG/CAA repeat alleles in neurological disorders and the functional implications. Clin Chim Acta (2009) 1.00
CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality. PLoS Pathog (2012) 1.00
Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J Nucl Med (2011) 0.99
A novel in vitro retinal differentiation model by co-culturing adult human bone marrow stem cells with retinal pigmented epithelium cells. Biochem Biophys Res Commun (2005) 0.99
Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea. Neuroimage (2009) 0.98
F-18 FDG PET superscan. Clin Nucl Med (2006) 0.97
Transient global amnesia: cerebral venous outflow impairment-insight from the abnormal flow patterns of the internal jugular vein. Ultrasound Med Biol (2007) 0.97
Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum Mol Genet (2007) 0.97
Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Neuroimage (2009) 0.96
In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. Int J Cancer (2009) 0.95
Cognitive reserve: a SPECT study of 132 Alzheimer's disease patients with an education range of 0-19 years. Dement Geriatr Cogn Disord (2005) 0.95
PRRT2 mutations in paroxysmal kinesigenic dyskinesia with infantile convulsions in a Taiwanese cohort. PLoS One (2012) 0.94
Fractal dimension analysis for quantifying cerebellar morphological change of multiple system atrophy of the cerebellar type (MSA-C). Neuroimage (2009) 0.93
Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging. J Nucl Med (2009) 0.93
CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur J Nucl Med Mol Imaging (2012) 0.92
Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis. Mol Med (2012) 0.92
Impairments in cognitive function and brain connectivity in severe asymptomatic carotid stenosis. Stroke (2012) 0.92
Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology (2010) 0.91
Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease. Ann Neurol (2012) 0.91
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. J Nucl Med (2006) 0.90
Construction of mutant TKGFP for real-time imaging of temporal dynamics of HIF-1 signal transduction activity mediated by hypoxia and reoxygenation in tumors in living mice. J Nucl Med (2009) 0.90
Asian origin for the worldwide-spread mutational event in Machado-Joseph disease. Arch Neurol (2007) 0.90
A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiol Aging (2012) 0.90
Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor. Am J Clin Pathol (2005) 0.89
Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS One (2012) 0.89
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: two novel mutations in the NOTCH3 gene in Chinese. J Neurol Sci (2006) 0.89
Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients. J Nucl Med (2003) 0.88
Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS One (2012) 0.88
Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol (2005) 0.87
Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma. J Chin Med Assoc (2006) 0.87
Multimodal evoked potentials of Kennedy's disease. Can J Neurol Sci (2007) 0.87
Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. Mov Disord (2002) 0.87
Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med (2006) 0.86
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant (2003) 0.86
Splice isoform-specific suppression of the Cav2.1 variant underlying spinocerebellar ataxia type 6. Neurobiol Dis (2011) 0.86
Simultaneous [99mTc]TRODAT-1 and [123I]ADAM brain SPECT in nonhuman primates. Mol Imaging Biol (2009) 0.86
Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. Arch Neurol (2012) 0.85
Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6. PLoS One (2012) 0.85
Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice. Anticancer Res (2006) 0.85
Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging (2003) 0.84
Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J Hepatol (2002) 0.84
Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Cancer Biother Radiopharm (2011) 0.84
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. Liver Int (2013) 0.84
Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography. Neuroimage (2009) 0.84
Imaging the impact of Nox4 in cycling hypoxia-mediated U87 glioblastoma invasion and infiltration. Mol Imaging Biol (2012) 0.84
Accuracy evaluation of RBC velocity measurement in nail-fold capillaries. Microvasc Res (2011) 0.84
Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer. Clin Exp Metastasis (2007) 0.83
1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med (2010) 0.83
Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Anticancer Res (2012) 0.83
Octarepeat changes of prion protein in Parkinson's disease. Parkinsonism Relat Disord (2008) 0.83
Hyperprolactinemia-related ¹³¹I uptake in nonlactating breasts. Clin Nucl Med (2012) 0.83
Unilateral thalamic hypometabolism in patients with temporal lobe epilepsy. J Formos Med Assoc (2008) 0.83
MicroPET imaging of noxious thermal stimuli in the conscious rat brain. Somatosens Mot Res (2010) 0.82
Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Anticancer Res (2009) 0.82
PET imaging of brain astrocytoma with 1-11C-acetate. Eur J Nucl Med Mol Imaging (2006) 0.82
Common mitochondrial DNA and POLG1 mutations are rare in the Chinese patients with adult-onset ataxia on Taiwan. J Neurol Sci (2007) 0.82
Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity. PLoS One (2010) 0.81
An imaging co-registration system using novel non-invasive and non-radioactive external markers. Eur J Nucl Med Mol Imaging (2003) 0.81
Honokiol inhibits hypoxia-inducible factor-1 pathway. Int J Radiat Biol (2011) 0.81
Prolonged cortical relay time of long latency reflex and central motor conduction in patients with spinocerebellar ataxia type 6. Clin Neurophysiol (2003) 0.81
Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study. Nucl Med Biol (2011) 0.81
Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. Eur Neurol (2003) 0.81
Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications. Mov Disord (2004) 0.81
Mutational analysis of the 5' non-coding region of GJB1 in a Taiwanese cohort with Charcot-Marie-Tooth neuropathy. J Neurol Sci (2013) 0.80
Optimizing the visualization of WB-PET images. IEEE Eng Med Biol Mag (2003) 0.80
The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma. Mol Imaging Biol (2012) 0.80
Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter. Anticancer Res (2007) 0.80
Infrared spectrometry based 13C-octanoic acid breath test in measuring human solid gastric emptying. J Gastroenterol Hepatol (2003) 0.80
Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases. J Neurol Sci (2007) 0.79
Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease. J Neurol Sci (2013) 0.79
Cellular characterization of MPZ mutations presenting with diverse clinical phenotypes. J Neurol (2010) 0.79
Feasibility and incremental benefit of puffed-cheek 18F-FDG PET/CT on oral cancer patients. Clin Nucl Med (2013) 0.79
Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease. Clin Biochem (2010) 0.79
Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Cancer Biother Radiopharm (2013) 0.79
Effects of long-term practice and task complexity on brain activities when performing abacus-based mental calculations: a PET study. Eur J Nucl Med Mol Imaging (2008) 0.79
In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells. PLoS One (2013) 0.79
Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice. Cancer Prev Res (Phila) (2011) 0.79
Congenital insensitivity to pain with anhidrosis in Taiwan: a morphometric and genetic study. Eur Neurol (2004) 0.79
A comparative study of primary and recurrent human glioblastoma multiforme using the small animal imaging and molecular expressive profiles. Mol Imaging Biol (2013) 0.78
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. J Gastroenterol Hepatol (2014) 0.78
Sleep disruption in spinocerebellar ataxia type 3: a genetic and polysomnographic study. J Chin Med Assoc (2012) 0.78
Leptin concentrations in the umbilical vein and artery. Relationship to maternal and neonatal anthropometry. J Reprod Med (2002) 0.78